Full Text View
Tabular View
Study Results
Related Studies
Cheno Effect on Transit in Health and IBS-C (Chenotransit)
This study has been completed.
Study NCT00912301   Information provided by Mayo Clinic

First Received on May 29, 2009.   Last Updated on May 29, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Constipation
Irritable Bowel Syndrome
More general conditions related to this trial
Colonic Diseases
Colonic Diseases, Functional
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Sodium chenodeoxycholate (NaCDC)
Placebo
Additional drug interventions recognized in this trial
Chenodeoxycholic Acid
More general drug interventions related to this trial
Cathartics
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Center for Research Resources (NCRR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services